{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:54:07Z","timestamp":1787673247494,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1007\/s11883-001-0011-1","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T19:03:21Z","timestamp":1179774201000},"page":"54-63","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis and treatment of hyperhomocysteinemia"],"prefix":"10.1007","volume":"3","author":[{"given":"Mary E.","family":"Keebler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3476(65)80121-4","volume":"66","author":"NA Carson","year":"1965","unstructured":"Carson NA, Dent CE, Field CM, Gaull GE: Homocystinuria. Clinical and pathological review of ten cases. J Pediatr 1965, 66:565\u2013583.","journal-title":"J Pediatr"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.1965.03090090017003","volume":"193","author":"RN Schimke","year":"1965","unstructured":"Schimke RN, McKusick VA, Huang T, Pollack AD: Homocystinuria. Studies of 20 families with 38 affected members. JAMA 1965, 193:711\u2013719.","journal-title":"JAMA"},{"key":"11_CR3","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS: Vascular pathology of homocysteinemia. Implications for the pathogenesis of arteriosclerosis. Am J Pathology 1969, 56:111\u2013128.","journal-title":"Am J Pathology"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198509193131201","volume":"313","author":"GH Boers","year":"1985","unstructured":"Boers GH, Smals AG, Trijbels FJ, et al.: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985, 313:709\u2013715.","journal-title":"N Engl J Med"},{"key":"11_CR5","first-page":"355","volume":"58","author":"LA Kluijtmans","year":"1996","unstructured":"Kluijtmans LA, van den Heuvel LP, Boers GH, et al.: Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996, 58:355\u2013341.","journal-title":"Am J Hum Genet"},{"key":"11_CR6","first-page":"17","volume":"58","author":"AG Motulsky","year":"1996","unstructured":"Motulsky AG: Nutritional Ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996, 58:17\u201320.","journal-title":"Am J Hum Genet"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.158.8.862","volume":"158","author":"NJ Wald","year":"1998","unstructured":"Wald NJ, Watt HC, Law MR, et al.: Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention [comment]. Arch Int Med 1998, 158:862\u2013867.","journal-title":"Arch Int Med"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0002-9149(99)80739-5","volume":"75","author":"K Dalery","year":"1995","unstructured":"Dalery K, Lussier-Cacan S, Selhub J, et al.: Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol 1995, 75:1107\u20131111.","journal-title":"Am J Cardiol"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199502023320502","volume":"332","author":"J Selhub","year":"1995","unstructured":"Selhub J, Jacques PR, Bostom AG, et al.: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995, 332:286\u2013291.","journal-title":"N Engl J Med"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willett WC, et al.: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992, 268:877\u2013881.","journal-title":"JAMA"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049\u20131057.","journal-title":"JAMA"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K, et al.: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991, 324:1149\u20131155.","journal-title":"N Engl J Med"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M Heijer den","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, et al.: Hyperhomocysteinemia as a risk factor for deep- vein thrombosis. N Engl J Med 1996, 334:759\u2013762.","journal-title":"N Engl J Med"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM199603213341204","volume":"334","author":"H Mandel","year":"1996","unstructured":"Mandel H, Brenner B, Berant M, et al.: Coexistence of hereditary homocystinuria and factor V Leiden\u2014effect on thrombosis. New Engl J Med 1996, 334:763\u2013768.","journal-title":"New Engl J Med"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, Robinson K: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277:1775\u20131781.","journal-title":"JAMA"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.98.3.204","volume":"98","author":"AR Folsom","year":"1998","unstructured":"Folsom AR, Nieto FJ, McGovern PG, et al.: Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998, 98:204\u2013210.","journal-title":"Circulation"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/01.ATV.17.10.1947","volume":"17","author":"RW Evans","year":"1997","unstructured":"Evans RW, Shaten BJ, Hempel JD, et al.: Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 1997, 17:1947\u20131953.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/01.ATV.20.7.1704","volume":"20","author":"SH Mudd","year":"2000","unstructured":"Mudd SH, Finkelstein JD, Refsum H, et al.: Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 2000, 20:1704\u20131706.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/edrv.20.5.0381","volume":"20","author":"V Fonseca","year":"1999","unstructured":"Fonseca V, Guba SC, Fink LM: Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocrine Rev 1999, 20:738\u2013759.","journal-title":"Endocrine Rev"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/clinchem\/41.7.991","volume":"41","author":"MT Shipchandler","year":"1995","unstructured":"Shipchandler MT, Moore EG: Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott Imx \u00ae Analyser. Clin Chem 1995, 41:991\u2013994.","journal-title":"Clin Chem"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/clinchem\/44.2.311","volume":"44","author":"F Frantzen","year":"1998","unstructured":"Frantzen F, Faaren AL, Alfheim I, Nordhei AK: Enyzme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998, 44:311\u2013316.","journal-title":"Clin Chem"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0021-9150(95)05529-6","volume":"116","author":"AG Bostom","year":"1995","unstructured":"Bostom AG, Jacques PF, Nadeau MR, et al.: Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis 1995, 116:147\u2013151.","journal-title":"Atherosclerosis"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ajcn\/64.4.641","volume":"64","author":"DW Jacobsen","year":"1996","unstructured":"Jacobsen DW: Determinants of hyperhomocysteinemia: a matter of nature and nurture. Am J Clin Nutr 1996, 64:641\u2013642.","journal-title":"Am J Clin Nutr"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ajcn\/64.4.587","volume":"64","author":"S Lussier-Cacan","year":"1996","unstructured":"Lussier-Cacan S, Xhignesse M, Piolot A, et al.: Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996, 64:587\u2013593.","journal-title":"Am J Clin Nutr"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","volume":"274","author":"O Nygard","year":"1995","unstructured":"Nygard O, Vollset SE, Refsum H, et al.: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995, 274:1526\u20131533.","journal-title":"JAMA"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0021-9150(94)05481-W","volume":"114","author":"MR Malinow","year":"1995","unstructured":"Malinow MR, Levenson J, Giral P, et al.: Role of blood pressure, uric acid, and hemorrheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 1995, 114:175\u2013183.","journal-title":"Atherosclerosis"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.ATV.14.3.460","volume":"14","author":"A Eckardstein von","year":"1994","unstructured":"von Eckardstein A, Malinow MR, Upson B, et al.: Effects of age, lipoproteins, and hemostatic parameters on the role of homocysteinemia as a cardiovascular risk factor in men. Arterioscler Thromb 1994, 14:460\u2013464.","journal-title":"Arterioscler Thromb"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.STR.26.5.795","volume":"26","author":"A Lindgren","year":"1995","unstructured":"Lindgren A, Brattstrom L, Norrving B, et al.: Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 1995, 26:795\u2013800.","journal-title":"Stroke"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2796.1995.tb01190.x","volume":"237","author":"F Landgren","year":"1995","unstructured":"Landgren F, Israelsson B, Lindgren A, et al.: Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995, 237:381\u2013388.","journal-title":"J Intern Med"},{"key":"11_CR30","first-page":"536","volume":"48","author":"SS Kang","year":"1991","unstructured":"Kang SS, Wong PW, Susmano A, et al.: Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991, 48:536\u2013545.","journal-title":"Am J Hum Genet"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/01.CIR.88.4.1463","volume":"88","author":"SS Kang","year":"1993","unstructured":"Kang SS, Passen EL, Ruggie N, et al.: Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993, 88:1463\u20131469.","journal-title":"Circulation"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, et al.: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995, 10:111\u2013113.","journal-title":"Nature Genet"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.17.3.569","volume":"17","author":"B Christensen","year":"1997","unstructured":"Christensen B, Frosst P, Lussier-Cacan S, et al.: Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Atheroscler Thromb Vasc Biol 1997, 17:569\u2013573.","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/01.CIR.94.10.2410","volume":"94","author":"J Ma","year":"1996","unstructured":"Ma J, Stampfer MJ, Hennekens CH, et al.: Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996, 94:2410\u20132416.","journal-title":"Circulation"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1161\/01.ATV.17.11.2924","volume":"17","author":"C Legnani","year":"1997","unstructured":"Legnani C, Palareti G, Grauso F, et al.: Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects. Arterioscler Thromb Vasc Biol 1997, 17:2924\u20132929.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.ATV.17.6.1157","volume":"17","author":"MR Malinow","year":"1997","unstructured":"Malinow MR, Nieto FJ, Kruger WD, et al.: The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997, 17:1157\u20131162.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR37","doi-asserted-by":"crossref","unstructured":"Ali NS, Powell J, Swaminathan R, Markus HS: The relationship between MTHFR genotype, serum homocysteine and folate levels. Biochem Soc Trans 1997, 25:386S.","DOI":"10.1042\/bst025386s"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","volume":"93","author":"PF Jacques","year":"1996","unstructured":"Jacques PF, Bostom AG, Williams RR, et al.: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulatiaon 1996, 93:7\u20139.","journal-title":"Circulatiaon"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"J Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PW, et al.: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270:2693\u20132698.","journal-title":"JAMA"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.279.5.359","volume":"279","author":"EB Rimm","year":"1998","unstructured":"Rimm EB, Willett WC, Hu FB, et al.: Folate and vitamin b from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998, 279:359\u2013364.","journal-title":"JAMA"},{"key":"11_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.279.5.359","volume":"279","author":"EB Rimm","year":"1998","unstructured":"Rimm EB, Willett WC, Hu FB, et al.: Folate and vitamin b from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998, 279:359\u2013364.","journal-title":"JAMA"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/clinchem\/43.1.141","volume":"43","author":"UC Garg","year":"1997","unstructured":"Garg UC, Zheng ZJ, Folsom AR, et al.: Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 1997, 43:141\u2013145.","journal-title":"Clin Chem"},{"key":"11_CR43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199804093381501","volume":"338","author":"MR Malinow","year":"1998","unstructured":"Malinow MR, Duell PB, Hess DL, et al.: Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998, 338:1009\u20131015.","journal-title":"N Engl J Med"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","volume":"316","author":"Homocysteine Lowering Trialists\u2019 Collaboration","year":"1998","unstructured":"Homocysteine Lowering Trialists\u2019 Collaboration: Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998, 316:894\u2013898.","journal-title":"BMJ"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0609.1993.tb00600.x","volume":"51","author":"E Joosten","year":"1993","unstructured":"Joosten E, Pelemans W, Devos P, et al.: Cobalamin absorption and serum homocysteine and methylmalonic acid in elderly subjects with low serum colbalamin. Eur J Haematol 1993, 51:25\u201330.","journal-title":"Eur J Haematol"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"J Eikelboom","year":"1999","unstructured":"Eikelboom J, Lonn E, Genest J, et al.: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131:363\u2013375.","journal-title":"Ann Intern Med"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","volume":"24","author":"E Arnesen","year":"1995","unstructured":"Arnesen E, Refsum H, Bonaa KH, et al.: Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995, 24:704\u2013709.","journal-title":"Int J Epidemiol"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","volume":"346","author":"IJ Perry","year":"1995","unstructured":"Perry IJ, Refsum H, Morris RW, et al.: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995, 346:1395\u20131398.","journal-title":"Lancet"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard O, Nordrehaug JE, Refsum H, et al.: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997, 337:230\u2013236.","journal-title":"N Engl J Med"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/01.ATV.18.12.1895","volume":"18","author":"CD Stehouwer","year":"1998","unstructured":"Stehouwer CD, Weijenberg MP, van den Berg M, et al.: Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol 1998, 18:1895\u20131901.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR51","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(96)03032-2","volume":"348","author":"M Petri","year":"1996","unstructured":"Petri M, Roubenoff R, Dallal GE, et al.: Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996, 348:1120\u20131124.","journal-title":"Lancet"},{"key":"11_CR52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archinte.159.1.38","volume":"159","author":"ML Bots","year":"1999","unstructured":"Bots ML, Launer LJ, Lindemans J, et al.: Homocysteine and short-term risk of Myocardial: infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 1999, 159:38\u201344.","journal-title":"Arch Intern Med"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/07315724.1996.10718578","volume":"15","author":"L Chasan-Taber","year":"1996","unstructured":"Chasan-Taber L, Selhub J, Rosenberg IH, et al.: A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 1996, 15:136\u2013143.","journal-title":"J Am Coll Nutr"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.STR.25.10.1924","volume":"25","author":"P Verhoef","year":"1994","unstructured":"Verhoef P, Hennekens CH, Malinow MR, et al.: A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994, 25:1924\u20131930.","journal-title":"Stroke"},{"key":"11_CR55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9149(96)00874-0","volume":"79","author":"P Verhoef","year":"1997","unstructured":"Verhoef P, Hennekens CH, Allen RH, et al.: Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol 1997, 79:799\u2013801.","journal-title":"Am J Cardiol"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","volume":"106","author":"G Alfthan","year":"1994","unstructured":"Alfthan G, Pekkanen J, Jauhiainen M, et al.: Relationship of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994, 106:9\u201319.","journal-title":"Atherosclerosis"},{"key":"11_CR57","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.79.6.1180","volume":"79","author":"MR Malinow","year":"1989","unstructured":"Malinow MR, Kang SS, Taylor LM, et al.: Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989, 79:1180\u20131188.","journal-title":"Circulation"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0026-0495(96)90211-5","volume":"45","author":"MN Munshi","year":"1996","unstructured":"Munshi MN, Stone A, Fink L, Fonseca V: Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 1996, 45:133\u2013135.","journal-title":"Metabolism"},{"key":"11_CR59","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-123-10-199511150-00002","volume":"123","author":"I Fermo","year":"1995","unstructured":"Fermo I, Vigano D\u2019Angelo S, Paroni R, et al.: Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995, 123:747\u2013753.","journal-title":"Ann Intern Med"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.17.5.989","volume":"17","author":"P Verhoef","year":"1997","unstructured":"Verhoef P, Kok FJ, Kruyssen DA, et al.: Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Atheroscler Thromb Vasc Biol 1997, 17:989\u2013995.","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"11_CR61","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/archinte.160.12.1834","volume":"160","author":"T Omland","year":"2000","unstructured":"Omland T, Samuelsson A, Hartford M, et al.: Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 2000, 160:1834\u20131840.","journal-title":"Arch Intern Med"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0002-9149(97)00161-6","volume":"79","author":"WS Aronow","year":"1997","unstructured":"Aronow WS, Ahn C, Schoenfeld MR: Association between plasma homocysteine and extracranial carotid arterial disease in older persons. Am J Cardiol 1997, 79:1432\u20131433.","journal-title":"Am J Cardiol"},{"key":"11_CR63","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.87.4.1107","volume":"87","author":"MR Malinow","year":"1993","unstructured":"Malinow MR, Nieto FJ, Szklo M, et al.: Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 1993, 87:1107\u20131113.","journal-title":"Circulation"},{"key":"11_CR64","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0002-8703(97)70148-0","volume":"133","author":"N Konecky","year":"1997","unstructured":"Konecky N, Malinow MR, Tunick PA, et al.: Correlation between plasma homocyst(e)ine and aortic atherosclerosis. Am Heart J 1997, 133:534\u2013540.","journal-title":"Am Heart J"},{"key":"11_CR65","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","volume":"95","author":"A Tawakol","year":"1997","unstructured":"Tawakol A, Omland T, Gerhard M, et al.: Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997, 95:1119\u20131121.","journal-title":"Circulation"},{"key":"11_CR66","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/jn\/124.10.1927","volume":"124","author":"JB Ubbink","year":"1994","unstructured":"Ubbink JB, Vermaak WJ, van der Merwe A, et al.: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994, 124:1927\u20131933.","journal-title":"J Nutr"},{"key":"11_CR67","first-page":"93","volume-title":"Homocysteine Metabolism: From Basic Science to Clinical Medicine","author":"JB Ubbink","year":"1998","unstructured":"Ubbink JB: Vitamin Status and hyperhomocysteinemia in a healthy population. In Homocysteine Metabolism: From Basic Science to Clinical Medicine. Edited by Graham I, Refsum H, Rosenburg I, Ueland PM. Boston: Kluwer Academic Publishers; 1998:93\u201398."},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.ATV.13.9.1253","volume":"13","author":"NP Dudman","year":"1993","unstructured":"Dudman NP, Wilcken DE, Wang J, et al.: Disordered methionine\/homocysteine metabolismin premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993, 13:1253\u20131254.","journal-title":"Arterioscler Thromb"},{"key":"11_CR69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/01.ATV.14.3.465","volume":"14","author":"DG Franken","year":"1994","unstructured":"Franken DG, Boers GH, Blom HJ, et al.: Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994, 14:465\u2013470.","journal-title":"Arterioscler Thromb"},{"key":"11_CR70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4615-5771-5_15","volume-title":"Homocysteine Metabolism: From Basic Science to Clinical Medicine","author":"GH Boers","year":"1997","unstructured":"Boers GH, van den Berg M, Franken DG: Treatment of mild hyperhomocysteinemia. In Homocysteine Metabolism: From Basic Science to Clinical Medicine. Edited by Graham I, Refsum H, Rosenburg I, Ueland PM. Boston: Kluwer Academic Publishers; 1997:111\u2013116."},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(90)90058-Q","volume":"81","author":"L Brattstr\u00f6m","year":"1990","unstructured":"Brattstr\u00f6m L, Israelsson B, Norrving B, et al.: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990, 81:51\u201360.","journal-title":"Atherosclerosis"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0741-5214(94)90230-5","volume":"20","author":"Berg van den","year":"1994","unstructured":"van den Berg, Franken DG, Boers GH, et al.: Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg 1994, 20:933\u2013940.","journal-title":"J Vasc Surg"},{"key":"11_CR73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11883-000-0063-7","volume":"2","author":"N Sharma","year":"1993","unstructured":"Sharma N, Andrews TC: Endothelial function as a therapeutic target in coronary artery disease. Curr Atheroscler Rep 1993, 2:303\u2013307.","journal-title":"Curr Atheroscler Rep"},{"key":"11_CR74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(99)07391-2","volume":"355","author":"EG Vermeulen","year":"2000","unstructured":"Vermeulen EG, Stehouwer CD, Twisk JW, et al.: Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomized, placebo-controlled trial. Lancet 2000, 355:517\u2013522.","journal-title":"Lancet"},{"key":"11_CR75","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/jama.281.22.2113","volume":"281","author":"F Nappo","year":"1999","unstructured":"Nappo F, De Rosa N, Marfella R, et al.: Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins, JAMA 1999, 281:2113\u20132118.","journal-title":"JAMA"},{"key":"11_CR76","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0735-1097(99)00469-6","volume":"34","author":"KS Woo","year":"1999","unstructured":"Woo KS, Chook P, Lolin Y, et al.: Folic acid improves arterial endothelial function in adults with hyperhomocystenemia, J Am Coll Cardiol 1999, 34:2002\u20132006.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR77","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9149(99)00575-5","volume":"84","author":"CL Chao","year":"1999","unstructured":"Chao CL, Chien KL, Lee YT: Effect of short term vitamin (Folic Acid, Vitamin B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia. Am J Cardiol 1999, 84:1359\u20131361.","journal-title":"Am J Cardiol"},{"key":"11_CR78","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1365-2141.1999.01780.x","volume":"107","author":"J Constans","year":"1999","unstructured":"Constans J, Blann AD, Resplandy F, et al.: Three months supplementation of hyperhomocysteinemic patients with folic acid and Vitamin B6 improves biological markers of endothelial dysfunction. Br J Haematol 1999, 107:776\u2013778.","journal-title":"Br J Haematol"},{"key":"11_CR79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0049-3848(99)00043-2","volume":"95","author":"A Undas","year":"1999","unstructured":"Undas A, Domagala TB, Jankowski M, Sczeklik A: Treatment of hyperhomocysteinemia with folic acid and Vitamins B12 and B6 attenuates thrombin generation. Thromb Res 1999, 95:281\u2013288.","journal-title":"Thromb Res"},{"key":"11_CR80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/13.1.106","volume":"13","author":"C Guldener Van","year":"1998","unstructured":"Van Guldener C, Janssen MJ, Lambert J, et al.: No change in impaired endothelial function after longterm folic acid therapy of hyperhomocysteinemia in haemodialysis patients. Nephrol Dial Transplant 1998, 13:106\u2013112.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-001-0011-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-001-0011-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-001-0011-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T06:52:36Z","timestamp":1587538356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-001-0011-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11883-001-0011-1","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}